Thursday February 21, 2019

The American Cancer Society Recommends Testing For Colon And Rectal Cancer At Age 45

Colon cancer, combined with rectal cancer, is the second leading cause of cancer death in the U.S.

0
//
The group said the initial test does not have to be a colonoscopy.
The American Cancer Society recommends people who are in good health and with a life expectancy of more than 10 years continue regular colorectal cancer screening through the age of 75. Pixabay

The American Cancer Society is recommending people start testing for colon and rectal cancer at age 45, rather than 50 as currently prescribed.

It also recommends people who are in good health and with a life expectancy of more than 10 years continue regular colorectal cancer screening through the age of 75.

“All of these tests are good tests"
“The best test is the test that gets done.”, said the cancer society’s Dr. Rich Wender. Pixabay

The group said the initial test does not have to be a colonoscopy, but instead could be one of several non-invasive tests, such as a home stool test available by prescription.

“All of these tests are good tests, and the choice should be offered to patients,” said the cancer society’s Dr. Rich Wender. “The best test is the test that gets done.”

The change in procedure is based on new information about a marked increase in the incidences of colorectal cancer, particularly rectal cancer, among younger individuals. Experts aren’t sure why there has been a 50 percent increase in cases since 1994.

Read More: According To WHO, Smoking Is A major Cause Of Death And Disease

Most colon cancer occurs in adults 55 and older, and the good news is that rates of cases and deaths have been falling for decades. Colon cancer, combined with rectal cancer, is the second leading cause of cancer death in the U.S.

This year, more than 140,000 Americans are expected to be diagnosed with it, and about 50,000 will die from it. (VOA)

 

Next Story

HPV Vaccination May Bring An End To Cervical Cancer In India by 2070

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

0
cancer
Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations. Pixabay

Human papillomavirus (HPV) screening and vaccination must be taken up on a war footing in countries like India to prevent 15 million cervical cancer deaths among women by 2050, a Lancet research said.

Causing the second-highest number of deaths among Indian women among cancer variants, cervical cancer, in a majority of cases, is caused by HPV, a group of more than 150 viruses.

The efforts might even result in cervical cancer being eliminated as a public health hazard in India by 2070-79, according to the study, published in The Lancet Oncology journal.

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

Cancer
“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS. Pixabay

If the high coverage of HPV vaccination and cervical screening cannot be achieved globally, over 44 million women could be diagnosed with cervical cancer in the next 50 years with two-thirds of these cases and an additional estimated 15 million deaths, would occur in countries with low and medium levels of development.

“More than two thirds of cases prevented would be in countries with low and medium levels of human development like India, Nigeria, and Malawi, where there has so far been limited access to HPV vaccination or cervical screening,” said lead author Professor Karen Canfell from the Cancer Council New South Wales in Australia.

However, large disparities exist in cervical screening and HPV vaccination coverage among countries.

“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS.

“While societal barriers prevent women from seeking medical help in advance, women are forced to come out at a later stage when the disease has reached an advanced stage,” she said.

cancer
Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said. Pixabay

However, Canfell says that despite the enormity of the problem, their findings suggest that “global elimination is within reach with tools that are already available, provided that both high coverage of HPV vaccination and cervical screening can be achieved.

Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations.

Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said.

Also Read: Indian IT Act Silent On Social Media’s Manipulative Role
“Diagnostic tests such as the pap smear are effective in identifying cancerous tendencies.

“However, these tests are available with a limited number of providers and largely within the cities. This makes screening sporadic and leaves out women who live in rural areas,” Aneja added. (IANS)